Clinical Trials on Diffuse Parenchymal Lung Diseases in Belgium

Total 2007 results

KU Leuven

Unknown

Innovation in Endobronchial Sampling

Diffuse Interstitial Lung Disease

Belgium
Boehringer Ingelheim

Completed

A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Scleroderma, Systemic

Spain, Germany, France, Belgium, Portugal, Netherlands
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma

Belgium
Lymphoma Study Association
Fondation ARC

Completed

ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

Lymphoma, Large-Cell, Diffuse

France, Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Endothelial Dysfunction in Covid-19 (ENDOCOVID)

Covid19 | Hypoxemic Respiratory Failure

Belgium
Lymphoma Study Association
Amgen

Completed

ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1

Diffuse Large-Cell Lymphoma

France, Belgium
Lymphoma Study Association
Fondation ARC

Terminated

R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma

Lymphoma, Large-Cell, Diffuse

France, Switzerland, Belgium
Brugmann University Hospital

Recruiting

Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?

Systemic Sclerosis

Belgium
Prometheus Biosciences, Inc., a subsidiary of Merck...

Recruiting

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) (ATHENA-SSc-ILD)

Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease

United States, Australia, Belgium, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Norway, Poland, Spain, Switzerland, United Kingdom
Lymphoma Study Association
Amgen

Terminated

ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma

Diffuse Large Cell Lymphoma

France, Belgium, Switzerland
Lymphoma Study Association

Completed

ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

Diffuse Large Cell Lymphoma

France, Belgium, Switzerland
Universitaire Ziekenhuizen KU Leuven

Completed

Codeine on Pharyngeal and Esophageal Motility

Esophageal Motility Disorders

Belgium
Lymphoma Study Association
Amgen

Completed

R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma

Diffuse Large Cell Lymphoma

France, Belgium, Switzerland
Prof Dr Jan Tack

Completed

The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers

Esophageal Motility Disorders

Belgium
Lymphoma Study Association

Completed

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

Lymphoma, Large-Cell, Diffuse

United States, Australia, Belgium, Czechia, Finland, Germany, Israel, Sweden, Switzerland, United Kingdom
University Hospital, Ghent

Completed

A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab

Early and Severe Systemic Sclerosis

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Botulinum Toxin Injection to Treat Diffuse Esophageal Spasm (Botox)

Esophageal Spasm, Diffuse

Belgium
The Lymphoma Academic Research Organisation
Pfizer

Completed

Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse

Diffuse Large B-Cell Lymphoma

France, Belgium
KU Leuven

Not yet recruiting

Diagnostic Value of Transbronchial Lung Cryobiopsy

Interstitial Lung Disease

Belgium
University Hospital, Ghent

Completed

Resistance Training in Patients With Chronic Obstructive Lung Disease (COPD): Whole Body Vibration Versus Conventional Resistance Training (REWORK)

COPD

Belgium
KU Leuven

Completed

Pulmonary Rehabilitation in Interstitial Lung Diseases

Interstitial Lung Disease

Belgium
KU Leuven

Completed

Enhancing Physical Activity in Patients With Interstitial Lung Disease

Interstitial Lung Disease | Interstitial Pulmonary Fibrosis

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Recruiting

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

NSCLC | Lung Diseases, Interstitial | Immunotherapy

Belgium
Brugmann University Hospital

Recruiting

Long-term Effects of SARS-CoV-2 on the Central Nervous System and One-year Follow-up of "Long COVID-19" Patients

Long Covid19

Belgium
Hasselt University

Completed

The Efficacy of Neuromuscular Electrical Stimulation to Attenuate Muscle Loss

Critical Illness | Muscle Disuse | Neuromuscular Electrical Stimulation (NMES)

Belgium
Sanofi

Completed

SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients (STARLYTE)

Diffuse Large B-cell Lymphoma

Belgium, Israel, Spain, Czechia, Turkey, Italy, United States, Poland, United Kingdom
Cliniques universitaires Saint-Luc- Université...

Completed

Correlation Between Lung UltraSound Score and Hypoxemia for Interstitial Syndrome in Emergency Department (O2LUSS)

Interstitial Lung Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma

Lymphoma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma (Follicular, Diffuse B-cel Lymphoma, PTLD and Mantle Cel Lymphoma)

Belgium
Centre Hospitalier Universitaire de Liege
Boehringer Ingelheim

Recruiting

Rheumatoid Arthritis-associated Interstitial Lung Disease Definition (RAID)

Rheumatoid Arthritis-Associated Interstitial Lung Disease

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Measurement of Viscoelastic Properties of Bronchopulmonary Secretions. (VLM-2)

Obstructive Pulmonary Disease

Belgium
The Lymphoma Academic Research Organisation

Recruiting

Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older

DLBCL

France, Belgium
KU Leuven

Completed

Confocal Laser Micro-endoscopy in Chronic Obstructive Pulmonary Disease (COPD) and Lung Transplant Recipients

Chronic Obstructive Pulmonary Disease | Lung Transplantation

Belgium
Erasme University Hospital

Recruiting

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases (FAPIPET)

Idiopathic Pulmonary Fibrosis | Pulmonary Fibrosis | FAP | Lung Fibrosis

Belgium
Pfizer

Completed

A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers

Lung Disease | Pulmonary Disease | Moxifloxacin

Belgium
Novartis

Completed

Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)

Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPD

Belgium
Pharmacyclics LLC.
Janssen Research & Development, LLC; Celgene Corporation

Completed

Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell Lymphoma

United States, United Kingdom, Belgium, Germany
Chiesi Farmaceutici S.p.A.

Completed

Investigation of the Effect of Inhibition of CYP3A4/5 by Itraconazole on the PK of CHF6001 (Tanimilast)

Chronic Obstructive Pulmonary Disease

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Six Minute Walking Test and Breath-holding

Chronic Obstructive Pulmonary Disease

Belgium
KU Leuven

Unknown

Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases (ACOS)

Chronic Obstructive Pulmonary Disease | Asthma | Overlap Syndrome

Belgium
Universitair Ziekenhuis Brussel
Vrije Universiteit Brussel

Completed

Nutrition and LOComotoric Rehabilitation in Long COVID-19 (UNLOCK)

COVID-19

Belgium
Synapse Biomedical

Completed

Clinical Study to Investigate Safety and Performance of NeuRx DPS in Patients Undergoing Bilateral Lung Transplantation

Chronic Obstructive Airway Disease

Belgium
University Hospital, Ghent
University Ghent; Kom Op Tegen Kanker

Active, not recruiting

MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer (MIDRIXNEO)

Non-small Cell Lung Cancer

Belgium
Hasselt University
Jessa Hospital

Completed

Oral β-Alanine Supplementation in Patients With COPD (BACOPD)

Chronic Obstructive Pulmonary Disease (COPD)

Belgium
Universitair Ziekenhuis Brussel
Vrije Universiteit Brussel

Completed

Blood Eosinophil Measurements in Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Comparison Between Sit-to-stand Test and Six-minute Walk Test in Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Belgium
KU Leuven

Unknown

Systemic Consequences and Comorbidities in Mild/Moderate Chronic Obstructive Pulmonary Disease (COPD), Time for Action!

Chronic Obstructive Pulmonary Disease

Belgium
Centre Hospitalier Universitaire de Liege

Active, not recruiting

Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study) (TEN)

Non-small Cell Lung Cancer

Belgium
GlaxoSmithKline

Completed

A Healthy Volunteer Study With Inhaled GSK573719 and Placebo

Pulmonary Disease, Chronic Obstructive

Belgium
Erasme University Hospital

Completed

Chronic Obstructive Pulmonary Disease: CT Features of Severe Exacerbation

COPD Exacerbation

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Endobronchial Valves in Persistent Air Leak

Malignant Neoplasm of Lung

Belgium

Clinical Trials on Diffuse Parenchymal Lung Diseases in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations